Cardiovascular companies develop diagnostics, therapies and research technologies for diseases affecting the heart and circulatory system. Their work supports earlier detection, improved disease management and the development of new treatments for cardiovascular conditions.
This category includes companies working on:
Browse 59 UK cardiovascular companies below.
Stabilised siRNA therapeutics platform targeting cardiovascular gene silencing
Argonaute RNA is a biopharmaceutical company developing small interfering RNA therapeutics for cardiovascular disease. Its siRNA platform uses proprietary chemical stabilisation…
Cell therapy for vascular regeneration in ischaemic and wound healing conditions
VascVersa is a Belfast-based regenerative medicine company developing cell therapies for vascular regeneration and repair. The company's technology uses vasoreparative cells to…
Therapeutic antibodies targeting the angiotensin AT1R pathway in cancer
aTen Therapeutics is a Scottish pre-clinical biotechnology company developing therapeutic monoclonal antibodies against the angiotensin-II type I receptor (AT1R), which is…
AI and multi-omics platform for cardiovascular drug target discovery
CardiaTec Biosciences is a Cambridge-based biotech applying artificial intelligence to large-scale multi-omic data to identify novel drug targets for cardiovascular diseases. Its…
Cardioprotective protein therapeutics for acute heart attack treatment
Forcefield Therapeutics is a biotechnology company developing protein-based therapeutics to protect heart muscle following acute myocardial infarction. The company's approach uses…
Mitochondrial transplantation platform to restore cellular energy and regeneration
Recondria Therapeutics is a developer of a mitochondrial transplantation platform designed to restore cellular energy, accelerate tissue recovery and support regenerative…
Cannabinoid medicines, neuroscience and oncology drug development
Jazz Pharmaceuticals is a global biopharmaceutical company focused on medicines for neuroscience and oncology. Its UK operations, centred at Kent Science Park in Sittingbourne,…
Science-led developer of clinically proven natural ingredients for supplements
Sibelius Natural Products is a science-led supplier of branded, clinically researched natural ingredients for the global nutritional supplement industry. The company uses its…
High-density e-textile sensors for AI-powered cardiac diagnostics
Polytecks is a University of Cambridge spin-out developing wearable, textile-based sensors for high-resolution bioelectrical mapping. Patented electrode arrays capture heart…
Independent global health research institute focused on chronic diseases
The George Institute for Global Health (UK) is an independent medical research institute conducting large-scale clinical trials, population studies, and health policy research on…
Predictive genetic tests for cancer and cardiovascular disease
GENinCode is a clinical-stage diagnostics company developing polygenic risk assessment tests for cardiovascular disease and ovarian cancer. Its portfolio includes CE-marked…